Rising colon cancer rates among young adults face insurance hurdles

A disturbing trend is emerging: colon cancer is increasingly affecting those in their 20s and 30s. But for many young adults experiencing alarming symptoms, accessing timely diagnosis remains a steep uphill battle due to insurance coverage gaps.

Coverage gaps delay diagnosis for young adults

While the Affordable Care Act (ACA) mandates coverage for colonoscopies for individuals over 45, a significant loophole leaves younger patients struggling. Caitlin Murphy, a cancer epidemiologist at the University of Chicago, explains: “Under 45, if you have symptoms like rectal bleeding, a colonoscopy would be considered a diagnostic test, and so it’s not going to be covered in the same way as a screening test would be.” This distinction creates a frustrating reality for those seeking answers.

Dominick, a 35-year-old software engineer from Florida, experienced this firsthand. After reporting bowel changes, stomach pain, and weight loss, his initial insurance approval was revoked just hours before his scheduled colonoscopy. He faced a $2,000 out-of-pocket cost, which he had to pay for with a credit card. The procedure ultimately revealed a precancerous polyp.

The situation is further complicated by the slow referral process many young adults encounter. “I hear at least once a week, someone who has had symptoms for years, and they get stuck in these referral loops,” notes Murphy. Doctors often initially attribute symptoms to common ailments like hemorrhoids or childbirth, delaying proper evaluation.

Experts like Rebecca Siegel of the American Cancer Society are advocating for a re-evaluation of the recommended screening age. The age was lowered to 45 in 2018, a change that faced considerable resistance. Siegel points out that pushing for the change risked taking screening away from older adults who face a higher risk and could exacerbate Health disparities affecting communities of color.

While early screening has likely improved outcomes since the age lowered, the debate continues. The scarcity of gastroenterologists and the inherent risks associated with colonoscopies add to the complexity. For those experiencing symptoms, alternative tests like Cologuard might offer a quicker path to diagnosis. Murphy and Siegel urge increased investment in research to identify the root causes of this alarming rise in younger patients.

“There are probably thousands of possibilities as to what’s causing the increase in colon cancer,” Murphy states. She suggests researchers employ advanced methods, like analyzing an individual’s entire lifetime exposure – the “exposome” – using mass spectrometry to pinpoint potential risk factors. The focus shouldn't solely be on lowering the screening age without understanding what’s driving the increase. The consequences of inaction are stark, and the rising number of young adults battling this disease demands immediate attention.